CA2755394A1 — Methods and compositions for cell-proliferation-related disorders
Assigned to Les Laboratoires Servier SAS · Expires 2010-09-16 · 16y expired
What this patent protects
Methods for identifying a cancer in a subject, or a subject that is susceptible to having a cancer, are provided. Such methods may include analyzing for elevated levels of 2-hydroxyglutarate (2HG) by MRS or LCMS, wherein elevated 2HG levels indicate the subject has, or is suscept…
USPTO Abstract
Methods for identifying a cancer in a subject, or a subject that is susceptible to having a cancer, are provided. Such methods may include analyzing for elevated levels of 2-hydroxyglutarate (2HG) by MRS or LCMS, wherein elevated 2HG levels indicate the subject has, or is susceptible to having, the cancer.
Drugs covered by this patent
- Tibsovo (IVOSIDENIB) · Servier
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.